The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in type 1 diabetes

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 17, Issue 4, 2004, Pages 211-216

  Lee, Scott W ^a   Cao, M ^a   Sajid, S ^a   Hayes, M ^a   Choi, L ^a   Rother, C ^b   de Leon R ^b  

^a Diabetes Treatment Center   (United States)

^b Medtronic MiniMed ^*  (United States)

Author keywords

Continuous subcutaneous insulin infusion (CSII); Dual wave bolus; Post prandial hyperglycemia

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART;

ADULT; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETIC ANGIOPATHY; DIABETIC MICROANGIOPATHY; DRUG DELIVERY SYSTEM; FEMALE; FOOD INTAKE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INTERMETHOD COMPARISON; LIPID DIET; MALE; MEDICAL ASSESSMENT; PATIENT MONITORING; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

AREA UNDER CURVE; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; KINETICS; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; PROSPECTIVE STUDIES;

EID: 8644291755     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Teuscher A., Schnell H., Wilson P.W.F.: Incidence of diabetic retinopathy and relationship to baseline plasma glucose and blood pressure. Diabetes Care 11: 246-251, 1988.
2. King H., Aubert R.E., Herman W.H.: Global burden of diabetes, 1995-2025. Prevalence, numerical estimates, and projections. Diabetes Care 21: 1414-1431, 1998.
3. Gavin J.R. 3rd: The importance of postprandial hyperglycemia. Int. J. Clin. Pract. Suppl. 14-17, 1999.
4. The Diabetes Control and Complications Trial (DCCT) Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. Research Group. N. Engl. J. Med. 329: 977-986, 1993
5. McCance D.R., Hanson R.L., Charles M., Jacobsson T.H., Pettitt D.J., Bennett P.H., Knowler W.C.: Comparison of tests for glycated haemoglobin and fasting two hour plasma glucose concentrations as diagnostic methods for diabetes. B.M.J. 308: 1323-1328, 1994.
6. 1c levels for diagnosing diabetes: Diagnostic criteria and performance revisited. Diabetes Care 20: 785-791, 1997.
7. 1c level. Diabetes Care 23: 1830-1834, 2000.
8. Stamler J., Vaccaro O., Neaton J.D., Wentworth D.: Diabetes, other risk factors, and 12 year cardiovascular mortality for men screened in multiple risk factor intervention trial. Diabetes Care 16: 434-444, 1993.
9. Lowe L.P., Liu K., Grennland P., Metzger B.E., Dyer A.R., Stamler J.: Diabetes, asymptomatic hyperglycemia and 22-year mortality in black and white men: The Chicago heart association detection project in industry study. Diabetes Care 20: 163-169, 1997.
10. Donahue R.P., Abbott R.D., Reed D.M., Yano K.: Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program. Diabetes 36:689-692, 1987.
11. Hanefeld M., Fischer S., Julius U., Schulze J., Schwanebeck U., Schmechel H., Ziegelasch H.J., Lindner J.: Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39: 1577-1587, 1996.
12. Jackson C.A., Yudkin J.S., Forrest R.D.: A comparison of the relationships of the glucose tolerance test and the glycated hemoglobin assay with diabetic vascular disease in the community. The Islington Diabetes Survey. Diabetes Res. Clin. Pract. 17: 111-123, 1992.
13. Katanas H.: Diets with a low glycemic index are ready for practice. Nutr. Today 34: 87-88, 1999.
14. Brand-Miller J., Foster-Powell K.: Diets with a low glycemic index: From theory to practice. Nutr. Today 34: 64-71, 1999.
15. Monro J.A.: Available carbohydrate and glycemic index combined in new data sets for managing glycemia and diabetes. J. Food Comp. Anal. 12: 71-82, 1999.
16. King A.B., Armstrong D.: A comparison of basal insulin delivery: continuous subcutaneous insulin infusion versus glargine. Diabetes Care 26: 1322, 2003.
17. Mastrototaro J.J.: The MiniMed continuous glucose monitoring system (CGMS). J. Pediatr. Endocrinol. Metab. 12: 751-758, 1999.
18. Boland E., Monsod T., Delucia M., Brandt C.A., Fernando S., Tamborlane W.V.: Limitations of conventional methods of self-monitoring blood glucose: lessons learned from 3-days of continuous glucose sensing in pediatric patients with Type 1 diabetes. Diabetes Care 24: 1858-1862, 2001.
19. Rebrin K., Steil G.M.: Can interstitial glucose assessment replace blood glucose measurements? Diabetes Technol. Ther. 2: 461-471, 2000.
20. Rebrin K., Steil G.M., Van Antwerp W.P., Mastrototaro J.J.: Subcutaneous glucose predicts plasma glucose independent of insulin: implication for continuous monitoring. Am. J. Physiol. 277: E561-E571, 1999.
21. Fredrickson L., Rubin R.R., Rubin S.: Fine-tuning your day-to-day control. In: Optimal pumping: a guide to good health with diabetes. MiniMed, Northridge, CA, 2001, pp. 11-30.
22. Ercan N., Gannon M.C., Nuttall F.Q.: Effect of added fat on the plasma glucose and insulin response to ingested potato given in various combinations as two meals in normal individuals. Diabetes Care 17: 1453-1459, 1994.
23. Robertson M.D., Henderson R.A., Vist G.E., Rumsey R.D.E.: Extended effects of evening meal carbohydrate-to-fat ratio on fasting and postprandial substrate metabolism. Am. J. Clin. Nutr. 75: 505-510, 2002.
24. Ahern J.A., Gatcomb P.M., Held N.A., Petit Jr. W.A., Tamborlane W.V.: Exaggerated hyperglycemia after a pizza meal in well-controlled diabetes. Diabetes Care 16: 578-580, 1993.
25. 13C-enriched durum wheat. Br. J Nutr. 86: 3-11, 2001.
26. Chase H.P., Saib S.Z., MacKenzie T., Hansen M.M., Garg S.K.: Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with Type 1 diabetes. Diabet. Med. 19: 317-321, 2002.
27. Heinemann L., Heise T., Wahl L. Ch., Trautmann M.E., Ampudia J., Starke A.A.R., Berger M.: Prandial glycaemia after a carbohydrate-rich meal in Type 1 diabetic patients: Using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin. Diabet. Med. 13: 625-629, 1996.
28. American Diabetes Association: Postprandial blood glucose [consensus statement]. Diabetes Care 24: 775-778, 2001.
29. 1c. Diabetes Care 23: 1236-1241, 2000.